Notes from Micro Archive
On this page, Mary DeMartino, BS, MT (ASCP) SM, and other technical experts at the Hygienic Laboratory will share information about protocols, best practices and news of interest to microbiology technologists.
Questions for Mary to address on this page can be sent via the contact page.
| Protocol for Clinical Laboratories with a Possible Vancomycin Intermediate or Resistant Staph aureus (VISA/VRSA) | |
| Algorithm for Testing S. aureuswith Vancomycin (VA) | |
| Reminder of Cessation of the Iowa Antibiotic Resistance Surveillance Program | |
| Starting December 31, 2011, SHL is pleased to announce the implementation of a new nucleic acid amplification test (NAAT) for the detection of Mycobacterium tuberculosis complex DNA directly from clinical specimens. | |
| Guidelines for Biosafety Lab Competency | |
| Results from the Multicenter study to evaluate diagnostic methods for detection and isolation of Campylobacter from stool | |
| Updated CDC guidelines now posted | |
| New Resistance Mechanism Identified | |
| Instructions for Submitting Suspected Carbapenem-resistant Enterobacteriaceae to the State Hygienic Lab for Confirmation of the New Delhi metallo-beta-lactamase (NDM-1) Resistance Mechanism | |
| CDC update on non-culture methods for direct detection of Campylobacter in stool | |
| Protocol For Laboratories Submitting Carey-Blair for Culture Comfirmation of Campylobacter Antigen Tests As Recommended in the CDC Summary Statement on Non-Culture Methods of Campylobacter Detection | |
| CDC Reminds Clinical Laboratories and Healthcare Infection Preventionists of their Role in the Search and Containment of Vancomycin-Resistant Staphylococcus aureus (VRSA) | |
| CDC VISA/VRSA Algorithm for Labs | |
| Protocol for Clinical Laboratories with a Possible Vancomycin Intermediate or Resistant Staph aureus (VISA/VRSA) |
